Recent Security Class Actions

Ardelyx Inc. Common Stock (NASDAQ: ARDX)

45 Days left to seek lead plaintiff status.

Company Name:Ardelyx Inc. Common Stock
Stock Symbol:NASDAQ: ARDX
Class Period Start:01/13/2025
Class Period End (inclusive):08/06/2026
Filing Deadline:11/16/2026

The complaint alleges defendants provided investors with material information concerning Ardelyx’s fiscal year 2026 revenue outlook for its two core drug products, XPHOZAH and IBSRELA, as well as their anticipated long-term growth. Defendants’ statements included, among other things, confidence in the Company’s continued commercial growth and ability to execute its commercial strategy to overcome payer and patient-access barriers, and its ability to achieve its projected revenue guidance and long-term growth targets. 

Ardelyx Inc. Common Stock (NASDAQ: ARDX) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address